Page last updated: 2024-11-09

5-carboxytetramethylrhodamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-carboxytetramethylrhodamine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

5-carboxytetramethylrhodamine : A tetramethylrhodamine compound having a carboxy substituent at the 5-position [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID2762602
CHEBI ID51657
SCHEMBL ID22204520
MeSH IDM0402623

Synonyms (37)

Synonym
CHEBI:51657
5-tamra
2-[3,6-bis(dimethylamino)xanthenium-9-yl]-5-carboxybenzoate
5-carboxytetramethylrhodamine
3-carboxy-4-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]benzoate
AKOS016000326
AKOS015902459
5-carboxytetramethyl rhodamine
91809-66-4
FT-0620195
HY-15942
2-(3,6-bis(dimethylamino)xanthylium-9-yl)-5-carboxybenzoate
DTXSID20376330
4-(3,6-bis(dimethylamino)xanthylium-9-yl)-3-carboxybenzoate
J-100075
spiro[isobenzofuran-1(3h),9'-[9h]xanthene]-5-carboxylicacid,3',6'-bis(dimethylamino)-3-oxo-
mfcd00269769
BP-23469
2-[3,6-bis(dimethylamino)xanthen-10-ium-9-yl]-5-carboxy-benzoate
BBL104181
5-tamra;4-(3,6-bis(dimethylamino)xanthylium-9-yl)-3-carboxybenzoate
STL557995
AKOS032949753
BCP20413
YMZMTOFQCVHHFB-UHFFFAOYSA-N
2-[3,6-bis(dimethylamino)xanthen-10-ium-9-yl]-5-carboxybenzoate
Q27122704
SCHEMBL22204520
MS-20808
5-carboxy-tetramethylrhodamine
A854490
F12248
5(6)-tamra acid
5-tamra acid
PD012483
SY069132
2-[3,6-bis(dimethylamino)xanthylium-9-yl]-5-carboxybenzoate

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The side effects of chemotherapy can be overcome by linking toxic agents to tumor-targeting peptides with cleavable linkers."( Controlling toxicity of Peptide-drug conjugates by different chemical linker structures.
Beck-Sickinger, AG; Böhme, D, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
fluorochromeA fluorescent dye used to stain biological specimens.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
xanthenes
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (27.27)29.6817
2010's16 (72.73)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.50 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.76 (4.65)
Search Engine Demand Index31.59 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]